NCT05530655 2026-01-13A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate CancerUniversity of RochesterPhase EARLY_PHASE1 Recruiting30 enrolled